Search Results - "Cheema, Gurtej S."

The Immunobiology of Systemic Sclerosis by Gu, Y. Stephanie, MD, Kong, James, MD, Cheema, Gurtej S., MD, Keen, Carl L., PhD, Wick, Georg, MD, Gershwin, M. Eric, MD

“…Objectives Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by vascular damage, autoimmunity, and excessive collagen deposition…”
Get full text

Multicentric Reticulohistiocytosis: a Rare Yet Challenging Disease by Islam, Arshia D., Naguwa, Stanley M., Cheema, Gurtej S., Hunter, John C., Gershwin, M. Eric

“…Multicentric reticulohistiocytosis (MRH) is a rare systemic inflammatory granulomatous disease that primarily manifests clinically with severe erosive…”
Get full text

Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases by Borchers, Andrea T, Leibushor, Naama, Cheema, Gurtej S, Naguwa, Stanley M, Gershwin, M. Eric

“…Abstract Biological agents represent a major advance in the treatment of rheumatic diseases, most particularly in the prevention of irreversible structural…”
Get full text

Revisiting Libman–Sacks Endocarditis: A Historical Review and Update by Lee, Jennifer L., Naguwa, Stanley M., Cheema, Gurtej S., Gershwin, M. Eric

“…Libman–Sacks (LS) endocarditis was first described by Libman and Sacks in 1924, and is characterized by sterile, verrucous valvular lesions with a…”
Get full text

Currents Concepts on the Immunopathology of Amyloidosis by Bhat, Anupama, Selmi, Carlo, Naguwa, Stanley M, Cheema, Gurtej S, Gershwin, M. Eric

“…Amyloidosis is defined as the extracellular accumulation at systemic or organ-specific level of insoluble low molecular weight protein fibrils manifesting a…”
Get full text

Lupus nephritis: A critical review by Borchers, Andrea T, Leibushor, Naama, Naguwa, Stanley M, Cheema, Gurtej S, Shoenfeld, Yehuda, Gershwin, M. Eric

“…Abstract Lupus nephritis remains one of the most severe manifestations of systemic lupus erythematosus associated with considerable morbidity and mortality. A…”
Get full text

Stevens–Johnson syndrome and toxic epidermal necrolysis by Borchers, Andrea T, Lee, Jennifer L, Naguwa, Stanley M, Cheema, Gurtej S, Gershwin, M. Eric

“…Abstract Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, but potentially life threatening, diseases characterized by widespread…”
Get full text

Colchicine Revisited by Bhat, Anupama, Naguwa, Stanley M., Cheema, Gurtej S., Gershwin, M. Eric

“…Purified from a Mediterranean plant nearly two centuries ago, colchicine has been discovered to inhibit many steps in the inflammatory process. The drug has…”
Get full text

The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases by Boren, Eric J, Cheema, Gurtej S, Naguwa, Stanley M, Ansari, Aftab A, Gershwin, M. Eric

“…Abstract Progressive multifocal leukoencephalopathy (PML) is a rare and devastating neurological disease with areas of demyelination in the central nervous…”
Get full text

The Geo-epidemiology of Temporal (Giant Cell) Arteritis by Lee, Jennifer L., Naguwa, Stanley M., Cheema, Gurtej S., Gershwin, M. Eric

“…Giant cell arteritis (GCA) is the most common vasculopathy in patients over the age of 50. The majority of data on the geo-epidemiology of GCA is derived from…”
Get full text

Acute rheumatic fever and its consequences: A persistent threat to developing nations in the 21st century by Lee, Jennifer L, Naguwa, Stanley M, Cheema, Gurtej S, Gershwin, M. Eric

“…Abstract Acute rheumatic fever (ARF) is an autoimmune, multi-system response secondary to molecular mimicry following Lancefield group A streptococcus (GAS)…”
Get full text

Increased CXCL8 (IL-8) expression in Multiple Sclerosis by Lund, Brett T., Ashikian, Nazely, Ta, Huy Q., Chakryan, Yervand, Manoukian, Krikor, Groshen, Susan, Gilmore, Wendy, Cheema, Gurtej S., Stohl, William, Burnett, Margaret E., Ko, David, Kachuck, Norman J., Weiner, Leslie P.

“…Multiple Sclerosis (MS) is a chronic inflammatory disease of the CNS which is characterized by large mononuclear cell infiltration and significant…”
Get full text

The use of methotrexate in rheumatoid arthritis by Borchers, Andrea T., Keen, Carl L., Cheema, Gurtej S., Gershwin, M.Eric

“…To address the long-term efficacy and toxicity issues related to methotrexate (MTX) and compare it with other disease-modifying antirheumatic drugs (DMARDs)…”
Get full text

Ankylosing Spondylitis: A Contemporary Perspective on Diagnosis and Treatment by Mansour, Mark, Cheema, Gurtej S, Naguwa, Stanley M, Greenspan, Adam, Borchers, Andrea T, Keen, Carl L, Gershwin, M. Eric

“…Objectives In recent years, great progress has been made in the development of diagnostic tools, therapeutic approaches, and validated outcome measures in the…”
Get full text

Interstitial lung disease in systemic lupus erythematosus by Cheema, Gurtej S, Quismorio, Francisco P

“…Systemic lupus erythematosis (SLE) is a heterogenous disease of unknown etiology. It is not uncommon to see pleuropulmonary involvement in isolation or along…”
Get full text

B Lymphocyte Stimulator Protein-Associated Increase in Circulating Autoantibody Levels May Require CD4 + T Cells: Lessons from HIV-Infected Patients by Stohl, William, Cheema, Gurtej S., Briggs, William S., Xu, Dong, Sosnovtseva, Svetlana, Roschke, Viktor, Ferrara, Dardo E., Labat, Kimberly, Sattler, Fred R., Pierangeli, Silvia S., Hilbert, David M.

“…To assess the helper T cell dependence of B lymphocyte stimulator (BLyS) protein-driven autoantibody production in vivo, serum levels of BLyS protein, total…”
Get full text

Pulmonary involvement in adult-onset Still’s disease by Cheema, Gurtej S, Quismorio, Francisco P

“…Adult-onset Still’s disease (AOSD) is a rare splenic disorder with an unknown cause. It is not uncommon for AOSD to involve other organs, such as the liver;…”
Get full text

Interstitial lung disease in systemic sclerosis by Cheema, Gurtej S, Quismorio, Francisco P

“…Systemic sclerosis is a multisystem disorder of unknown etiology and involves organ systems such as the skin, peripheral vasculature, gastrointestinal tract,…”
Get full text

Elevated serum B lymphocyte stimulator levels in patients with systemic immune–based rheumatic diseases by Cheema, Gurtej S., Roschke, Viktor, Hilbert, David M., Stohl, William

“…Objective To determine whether serum levels of B lymphocyte stimulator (BLyS) are elevated in patients with systemic immune–based rheumatic diseases and…”
Get full text

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations by Stohl, William, Metyas, Samy, Tan, Soon‐Min, Cheema, Gurtej S., Oamar, Bonifacia, Xu, Dong, Roschke, Viktor, Wu, Youmei, Baker, Kevin P., Hilbert, David M.

“…Objective To assess the overexpression of B lymphocyte stimulator (BLyS) over time in patients with systemic lupus erythematosus (SLE). Methods Sixty‐eight SLE…”
Get full text